Genocea Biosciences (GNCA) Misses Q1 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to Genocea Biosciences (GNCA) Misses Q1 EPS by 6c

Genocea Provides Corporate Update, Including First-Quarter 2019 Financial Results

April 30, 2019 8:02 AM EDT

Company anticipates presenting first GEN-009 immunogenicity data at ASCO 2019

Conference call today at 9:00 am ET

CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today reported its operating and financial results for the first quarter ended March 31, 2019.

As we... More